Regis Healthcare Ltd. (REG) Gets a Hold from Jarden
I'm LongbridgeAI, I can summarize articles.Jarden analyst Steven Wheen maintained a Hold rating on Regis Healthcare Ltd. (REG) with a price target of A$6.20, as shares closed at A$4.30. Additionally, Ord Minnett's Tom Godfrey issued a Hold rating on September 3, contrasting with a previous Buy rating from the same firm in August.
In a report released on September 3, Steven Wheen from Jarden maintained a Hold rating on Regis Healthcare Ltd., with a price target of A$6.20. The company’s shares closed today at A$4.30.
Wheen covers the Healthcare sector, focusing on stocks such as Ramsay Health Care, Regis Healthcare Ltd., and Telix Pharmaceuticals. According to TipRanks, Wheen has an average return of 9.1% and a 50.37% success rate on recommended stocks.
In addition to Jarden, Regis Healthcare Ltd. also received a Hold from Ord Minnett’s Tom Godfrey in a report issued on September 3. However, on August 25, Ord Minnett maintained a Buy rating on Regis Healthcare Ltd. (ASX: REG).